Patent Valuation: Is Fair Market Fair?
Publish place: 1st International Congress of Bioethics
Publish Year: 1384
Type: Conference paper
Language: English
View: 1,640
This Paper With 10 Page And PDF Format Ready To Download
- Certificate
- I'm the author of the paper
Export:
Document National Code:
BIOETHICS01_041
Index date: 31 December 2007
Patent Valuation: Is Fair Market Fair? abstract
In today’s “knowledge Econom”, banks, investors , and insurer have come to acknowledge that patent rights have considerable influence on the value of enterprises and on the stability of patent- based business models. However , the ability to leverage this presumed value is impaired by regulatory and professional ambiguity on several points. With the united states, Europe, and Japan’s patent systems facing unprecedented quality deficiencies , financiers appropriately subject the notion that patents can be business assets to considerable scrutiny. Due to a public lack of confidence, fueled by increasingly visible patent-related market perturbations, both policy and process reforms must precede the maturing of the patent – based financial markets. In this paper, policy and process are examined in the context of: 1) the role the public sector in the oversight of quality patent issuance ‘ 2) patent accountability in financial reporting; 3) practices that enable the use of patents in financial transactions. These topics are addressed in light of their collective impact on accepted caluation practices.
Patent Valuation: Is Fair Market Fair? authors
David Martin
Prepared for "patents in the Financial Services Industry: what you need to know"